Tech Company Financing Transactions
Envisia Therapeutics Funding Round
On 6/30/2015, Envisia Therapeutics raised $4.7 million in funding from Canaan Partners and Pappas Ventures.
Transaction Overview
Company Name
Announced On
6/30/2015
Transaction Type
Venture Equity
Amount
$4,749,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
P.O. Box 110065
Research Triangle Park, NC 27709
USA
Research Triangle Park, NC 27709
USA
Phone
Website
Email Address
Overview
As many as 285 million people suffer from disease-related visual impairments and blindness,1 but an estimated 80 percent of these visual impairments are actually preventable2.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Financial Officer
Eric Linsley
President
Benjamin Yerxa
VP - Bus. Development
Tomas Navratil
Browse more venture capital transactions:
Prev: 6/30/2015: Sweet Bio venture capital transaction
Next: 6/30/2015: Associated Material Processing venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs